Consistently, the tumorigenesis capacity of the human CSCs and the tumor growth in nude mice were markedly reduced by MAP2 shRNA1 and slightly knocked down by MAP2 shRNA2 (Figure 7). This evidence concerns the gene MAP2 and neoplasm.